Clinical Trials · NCT01667406
The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Imperial College London
- Enrollment
- 175
- Start date
- Jun 2012
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Percentage of Oocyte Maturation